Ranitidine tablets IP 150mg are a formulation of ranitidine, a medication used to decrease stomach acid production [1]. This dosage strength is commonly prescribed for various gastrointestinal conditions [2].
What is Ranitidine Used For?
Ranitidine is primarily prescribed to treat and prevent ulcers in the stomach and duodenum (the first part of the small intestine) [2]. It is also used to treat gastroesophageal reflux disease (GERD), a condition where stomach acid frequently flows back into the esophagus, causing heartburn and potential damage [2]. Additionally, it can manage conditions like Zollinger-Ellison syndrome, which causes the stomach to produce too much acid [2].
Why Was Ranitidine Recalled?
Concerns arose regarding the presence of N-nitrosodimethylamine (NDMA), a probable human carcinogen, in ranitidine products [3]. Regulatory agencies, including the U.S. Food and Drug Administration (FDA), found that NDMA levels could increase in ranitidine products over time and upon storage under different conditions [3]. This led to voluntary recalls by manufacturers and the eventual withdrawal of ranitidine from many markets [4].
Are There Alternatives to Ranitidine?
Yes, there are several effective alternatives to ranitidine available for treating acid-related disorders. These include other proton pump inhibitors (PPIs) like omeprazole, lansoprazole, and pantoprazole, as well as H2 blockers that do not carry the same NDMA concerns, such as famotidine [5]. These alternatives work by reducing stomach acid production, similar to ranitidine, but have different chemical profiles [5].
Where Can I Find Information on Drug Patents for Ranitidine?
Information on drug patents related to ranitidine and its formulations, including any potential patent expirations or challenges, can be found on DrugPatentWatch.com [6]. This resource tracks patent statuses and exclusivities for pharmaceutical products worldwide [6].
What is the Difference Between Ranitidine and Famotidine?
Ranitidine and famotidine are both H2 blockers, a class of drugs that reduce the amount of acid produced by the stomach. However, they are distinct chemical compounds. Famotidine has generally been considered to have a lower risk of NDMA contamination compared to ranitidine, and it has largely replaced ranitidine for many indications following the latter's recalls [5].
What are the Risks Associated with NDMA Contamination?
N-nitrosodimethylamine (NDMA) is classified as a probable human carcinogen. Exposure to NDMA, especially at elevated levels over time, has been associated with an increased risk of cancer [3]. The discovery of NDMA in ranitidine prompted regulatory action to protect public health [3][4].
Sources
1. Ranitidine - Wikipedia
2. Ranitidine - Uses, Dosage, Side Effects, Warnings - Drugs.com
3. FDA Investigating Potential Contamination of Ranitidine Products
4. FDA Requests Removal of All Ranitidine Products from the U.S. Market
5. H2 Blockers - NHS
6. DrugPatentWatch.com